CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,778 | -29.4% | 10,130 | -13.0% | 0.00% | 0.0% |
| Q2 2023 | $394,877 | +51.4% | 11,638 | +98.8% | 0.00% | – |
| Q4 2022 | $260,868 | -57.5% | 5,853 | -73.2% | 0.00% | -100.0% |
| Q3 2022 | $614,000 | +4.4% | 21,843 | +0.1% | 0.00% | -50.0% |
| Q2 2022 | $588,000 | -65.8% | 21,811 | -56.8% | 0.00% | -66.7% |
| Q1 2022 | $1,719,000 | +14.9% | 50,487 | +82.1% | 0.01% | +20.0% |
| Q3 2021 | $1,496,000 | +976.3% | 27,718 | +158.7% | 0.01% | – |
| Q2 2020 | $139,000 | – | 10,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |